Workflow
*ST长药: 关于取消2025年第三次临时股东会部分子议案并增加临时提案的补充通知公告

Group 1 - The company announced the cancellation of part of the agenda for the third extraordinary general meeting of shareholders scheduled for July 14, 2025, and added a temporary proposal to nominate Wei Jian as an independent director candidate [1][2] - The controlling shareholder, Shengshi Fenghua, holds 35,423,600 shares, accounting for 10.11% of the total share capital, and has submitted the temporary proposal in accordance with relevant regulations [2] - The meeting will be held in a hybrid format, combining on-site and online participation, with specific voting times outlined for both methods [3][4] Group 2 - The meeting will review several proposals, including the election of independent directors and amendments to the company's articles of association [5][9] - Shareholders can participate in the voting process through the Shenzhen Stock Exchange trading system and internet voting system, with detailed procedures provided [10][12] - The company has established registration procedures for both corporate and individual shareholders to attend the meeting, including provisions for proxy voting [4][7]